Review




Structured Review

Statista Inc age group
Age Group, supplied by Statista Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/age group/product/Statista Inc
Average 86 stars, based on 1 article reviews
age group - by Bioz Stars, 2026-05
86/100 stars

Images



Similar Products

94
MedChemExpress aging foxo4 dri group
<t>FOXO4-DRI</t> <t>can</t> effectively maintain vascular function in naturally aging mice. (A) Western blot experiments were conducted and quantitatively analyzed to determine the changes in protein levels of Ki-67, Lamin B, P21, P16, and γ-H2AX in the aortas of naturally aged mice after FOXO4-DRI or PBS treatment. n ≥ 4 per group. (B) RT-qPCR analysis was performed to examine the mRNA levels of Il-1β, Il-6, Cxcl15 , and Tnf-α in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 3 per group. (C) Representative SA-β-Gal staining and quantitative analysis were performed to determine the number of positive cells in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. (D) Representative HE staining and quantitative analysis were performed to evaluate the thickness of the aortas in naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. (E) Color Doppler imaging and analysis were performed to detect and analyze the structural and blood flow conditions of the aortas in naturally aged mice after FOXO4-DRI and PBS treatments. n = 6 per group. (F) Representative DHE staining and quantitative analysis were performed to assess the ROS levels in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.
Aging Foxo4 Dri Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aging foxo4 dri group/product/MedChemExpress
Average 94 stars, based on 1 article reviews
aging foxo4 dri group - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Bio-Rad m ab biorad bioplex 2200 hiv group m ab
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
M Ab Biorad Bioplex 2200 Hiv Group M Ab, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m ab biorad bioplex 2200 hiv group m ab/product/Bio-Rad
Average 93 stars, based on 1 article reviews
m ab biorad bioplex 2200 hiv group m ab - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

86
Sandoz v v midazolam sandoz group ag switzerland
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
V V Midazolam Sandoz Group Ag Switzerland, supplied by Sandoz, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/v v midazolam sandoz group ag switzerland/product/Sandoz
Average 86 stars, based on 1 article reviews
v v midazolam sandoz group ag switzerland - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Reddit Inc overrepresent certain age groups
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
Overrepresent Certain Age Groups, supplied by Reddit Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/overrepresent certain age groups/product/Reddit Inc
Average 86 stars, based on 1 article reviews
overrepresent certain age groups - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Wolters Kluwer Health non recurrent rd group id m f age eye bcva n
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
Non Recurrent Rd Group Id M F Age Eye Bcva N, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non recurrent rd group id m f age eye bcva n/product/Wolters Kluwer Health
Average 86 stars, based on 1 article reviews
non recurrent rd group id m f age eye bcva n - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

94
Selleck Chemicals ag490 group
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
Ag490 Group, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ag490 group/product/Selleck Chemicals
Average 94 stars, based on 1 article reviews
ag490 group - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

86
Moderna age group
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
Age Group, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/age group/product/Moderna
Average 86 stars, based on 1 article reviews
age group - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Lafayette Instrument Co Inc 15 age groups
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
15 Age Groups, supplied by Lafayette Instrument Co Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/15 age groups/product/Lafayette Instrument Co Inc
Average 86 stars, based on 1 article reviews
15 age groups - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Statista Inc age group
Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad <t>BioPlex</t> <t>2200</t> p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).
Age Group, supplied by Statista Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/age group/product/Statista Inc
Average 86 stars, based on 1 article reviews
age group - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


FOXO4-DRI can effectively maintain vascular function in naturally aging mice. (A) Western blot experiments were conducted and quantitatively analyzed to determine the changes in protein levels of Ki-67, Lamin B, P21, P16, and γ-H2AX in the aortas of naturally aged mice after FOXO4-DRI or PBS treatment. n ≥ 4 per group. (B) RT-qPCR analysis was performed to examine the mRNA levels of Il-1β, Il-6, Cxcl15 , and Tnf-α in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 3 per group. (C) Representative SA-β-Gal staining and quantitative analysis were performed to determine the number of positive cells in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. (D) Representative HE staining and quantitative analysis were performed to evaluate the thickness of the aortas in naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. (E) Color Doppler imaging and analysis were performed to detect and analyze the structural and blood flow conditions of the aortas in naturally aged mice after FOXO4-DRI and PBS treatments. n = 6 per group. (F) Representative DHE staining and quantitative analysis were performed to assess the ROS levels in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

doi: 10.3389/fbioe.2025.1729166

Figure Lengend Snippet: FOXO4-DRI can effectively maintain vascular function in naturally aging mice. (A) Western blot experiments were conducted and quantitatively analyzed to determine the changes in protein levels of Ki-67, Lamin B, P21, P16, and γ-H2AX in the aortas of naturally aged mice after FOXO4-DRI or PBS treatment. n ≥ 4 per group. (B) RT-qPCR analysis was performed to examine the mRNA levels of Il-1β, Il-6, Cxcl15 , and Tnf-α in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 3 per group. (C) Representative SA-β-Gal staining and quantitative analysis were performed to determine the number of positive cells in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. (D) Representative HE staining and quantitative analysis were performed to evaluate the thickness of the aortas in naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. (E) Color Doppler imaging and analysis were performed to detect and analyze the structural and blood flow conditions of the aortas in naturally aged mice after FOXO4-DRI and PBS treatments. n = 6 per group. (F) Representative DHE staining and quantitative analysis were performed to assess the ROS levels in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.

Article Snippet: In the natural aging + FOXO4-DRI group, mice received intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days during the same period, followed by tissue collection.

Techniques: Western Blot, Quantitative RT-PCR, Staining, Imaging, Two Tailed Test

FOXO4-DRI can effectively maintain vascular function in progeroid mice. (A) Western blot experiments were conducted and quantitatively analyzed to determine the changes in protein levels of Ki-67, Lamin B, P21, P16, and γ-H2AX in the aortas of progeroid mice after FOXO4-DRI or PBS treatment. n ≥ 4 per group. (B) RT-qPCR analysis was performed to examine the mRNA levels of Il-1β , Il-6 , Cxcl15 , and Tnf-α in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. n = 3 per group. (C) Representative SA-β-Gal staining and quantitative analysis were performed to determine the number of positive cells in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. Scale bar = 100 μm. n = 5 per group. (D) Representative HE staining and quantitative analysis were performed to evaluate the thickness in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. Scale bar = 100 μm. n = 5 per group. (E) Color Doppler imaging and analysis were performed to detect and analyze the structural and blood flow conditions in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. n = 5 per group. (F) Representative DHE staining and quantitative analysis were performed to assess the ROS levels in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

doi: 10.3389/fbioe.2025.1729166

Figure Lengend Snippet: FOXO4-DRI can effectively maintain vascular function in progeroid mice. (A) Western blot experiments were conducted and quantitatively analyzed to determine the changes in protein levels of Ki-67, Lamin B, P21, P16, and γ-H2AX in the aortas of progeroid mice after FOXO4-DRI or PBS treatment. n ≥ 4 per group. (B) RT-qPCR analysis was performed to examine the mRNA levels of Il-1β , Il-6 , Cxcl15 , and Tnf-α in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. n = 3 per group. (C) Representative SA-β-Gal staining and quantitative analysis were performed to determine the number of positive cells in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. Scale bar = 100 μm. n = 5 per group. (D) Representative HE staining and quantitative analysis were performed to evaluate the thickness in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. Scale bar = 100 μm. n = 5 per group. (E) Color Doppler imaging and analysis were performed to detect and analyze the structural and blood flow conditions in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. n = 5 per group. (F) Representative DHE staining and quantitative analysis were performed to assess the ROS levels in the aortas of progeroid mice after FOXO4-DRI and PBS treatments. n = 5 per group. Scale bar = 100 μm. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.

Article Snippet: In the natural aging + FOXO4-DRI group, mice received intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days during the same period, followed by tissue collection.

Techniques: Western Blot, Quantitative RT-PCR, Staining, Imaging, Two Tailed Test

FOXO4-DRI can alleviate endothelial cell senescence induced by OGD. (A) Western blot analysis was conducted to quantify the changes in protein levels of Ki-67, Lamin B, P21, P16, and γ-H2AX in senescent HUVECs following treatment with FOXO4-DRI or PBS, with n ≥ 4 per group. (B) Representative immunofluorescence analysis (green for Ki-67, blue for DAPI) was performed to assess the number of Ki-67 positive HUVECs in different groups, with n = 5 per group and scale bar = 40 μm. (C) Fluorescent staining was carried out to analyze the content and localization changes of P21 and γ-H2AX in different groups, with n = 5 per group and scale bar = 40 μm. (D) Representative SA-β-GAL staining and quantification were performed to evaluate the number of positive cells in different groups, with n = 5 per group and scale bar = 100 μm. (E) Tube formation assays were conducted to analyze relative tube lengths in different groups, with n = 5 per group and scale bar = 400 μm. (F) Representative DHE staining and quantification were carried out to evaluate the number of DHE-positive cells in different groups, with n = 5 per group and scale bar = 100 μm. (G) Scratch assays were performed to assess endothelial cell migration coverage at 0, 12, 24, and 36 h in different groups, with n = 5 per group and scale bar = 400 μm. Data are represented as mean ± SEM. Statistical analysis assessed by 2-way RM ANOVA. (H) RT-qPCR analysis was performed to detect mRNA levels of IL-6 , IL-8 , IL-1β , and TNF-α in different groups, with n = 3 per group. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

doi: 10.3389/fbioe.2025.1729166

Figure Lengend Snippet: FOXO4-DRI can alleviate endothelial cell senescence induced by OGD. (A) Western blot analysis was conducted to quantify the changes in protein levels of Ki-67, Lamin B, P21, P16, and γ-H2AX in senescent HUVECs following treatment with FOXO4-DRI or PBS, with n ≥ 4 per group. (B) Representative immunofluorescence analysis (green for Ki-67, blue for DAPI) was performed to assess the number of Ki-67 positive HUVECs in different groups, with n = 5 per group and scale bar = 40 μm. (C) Fluorescent staining was carried out to analyze the content and localization changes of P21 and γ-H2AX in different groups, with n = 5 per group and scale bar = 40 μm. (D) Representative SA-β-GAL staining and quantification were performed to evaluate the number of positive cells in different groups, with n = 5 per group and scale bar = 100 μm. (E) Tube formation assays were conducted to analyze relative tube lengths in different groups, with n = 5 per group and scale bar = 400 μm. (F) Representative DHE staining and quantification were carried out to evaluate the number of DHE-positive cells in different groups, with n = 5 per group and scale bar = 100 μm. (G) Scratch assays were performed to assess endothelial cell migration coverage at 0, 12, 24, and 36 h in different groups, with n = 5 per group and scale bar = 400 μm. Data are represented as mean ± SEM. Statistical analysis assessed by 2-way RM ANOVA. (H) RT-qPCR analysis was performed to detect mRNA levels of IL-6 , IL-8 , IL-1β , and TNF-α in different groups, with n = 3 per group. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.

Article Snippet: In the natural aging + FOXO4-DRI group, mice received intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days during the same period, followed by tissue collection.

Techniques: Western Blot, Immunofluorescence, Staining, Migration, Quantitative RT-PCR, Two Tailed Test

FOXO4-DRI can block the interaction between P53 and FOXO4. (A) The FOXO4-P53 interaction was analyzed through co-immunoprecipitation in OGD-treated HUVECs, in different groups, with n = 3 per group. (B) Western blot analysis quantified changes in protein levels of pSer46-P53 and P53 in different groups, with n = 5 per group. (C) Western blot analysis quantified changes in protein levels of pSer46-P53 and P53 in different groups, with n = 5 per group. (D) Western blot analysis was performed to examine the distribution of pSer46-P53 and P53 in the cytoplasm and nucleus of HUVECs in different groups. With n = 5 per group. (E) Subcellular localization of pSer46-P53 in different groups of HUVECs was analyzed using representative immunofluorescence staining (pSer46-P53 in green, DAPI in blue), with n = 5 per group, scale bar = 40 μm. (F) Immunofluorescence detection and analysis of subcellular localization of pSer46-P53 and FOXO4 in aortic sections of naturally aged mice (pSer46-P53 in green, FOXO4 in red, DAPI in blue), with n = 5 per group, scale bar = 20 μm. (G) Immunofluorescence detection and analysis of subcellular localization of pSer46-P53 and FOXO4 in aortic sections of progeroid mice (pSer46-P53 in green, FOXO4 in red, DAPI in blue), with n = 5 per group, scale bar = 20 μm. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

doi: 10.3389/fbioe.2025.1729166

Figure Lengend Snippet: FOXO4-DRI can block the interaction between P53 and FOXO4. (A) The FOXO4-P53 interaction was analyzed through co-immunoprecipitation in OGD-treated HUVECs, in different groups, with n = 3 per group. (B) Western blot analysis quantified changes in protein levels of pSer46-P53 and P53 in different groups, with n = 5 per group. (C) Western blot analysis quantified changes in protein levels of pSer46-P53 and P53 in different groups, with n = 5 per group. (D) Western blot analysis was performed to examine the distribution of pSer46-P53 and P53 in the cytoplasm and nucleus of HUVECs in different groups. With n = 5 per group. (E) Subcellular localization of pSer46-P53 in different groups of HUVECs was analyzed using representative immunofluorescence staining (pSer46-P53 in green, DAPI in blue), with n = 5 per group, scale bar = 40 μm. (F) Immunofluorescence detection and analysis of subcellular localization of pSer46-P53 and FOXO4 in aortic sections of naturally aged mice (pSer46-P53 in green, FOXO4 in red, DAPI in blue), with n = 5 per group, scale bar = 20 μm. (G) Immunofluorescence detection and analysis of subcellular localization of pSer46-P53 and FOXO4 in aortic sections of progeroid mice (pSer46-P53 in green, FOXO4 in red, DAPI in blue), with n = 5 per group, scale bar = 20 μm. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: In the natural aging + FOXO4-DRI group, mice received intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days during the same period, followed by tissue collection.

Techniques: Blocking Assay, Immunoprecipitation, Western Blot, Immunofluorescence, Staining, Two Tailed Test

FOXO4-DRI promotes apoptosis in senescent cells. (A) Western blot analysis quantified changes in protein levels of BAX, Bcl2, and c-Caspase3 in different groups, with n = 5 per group. (B) Western blot analysis assessed changes in protein levels of BAX, Bcl2, and c-Caspase3 in the aortas of naturally aged mice after FOXO4-DRI or PBS treatment, with n = 5 per group. (C) Representative TUNEL staining and quantitative analysis were conducted to determine the number of positive cells in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments, with n = 5 per group and scale bar = 100 μm. (D) Representative TUNEL staining and quantification evaluated the number of TUNEL-positive cells across different groups with n = 5 per group and scale bar = 20 μm. (E) Flow cytometry analysis was used to quantitatively assess the number of Annexin V-positive cells in different groups, with a sample size of n = 5 per group. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

doi: 10.3389/fbioe.2025.1729166

Figure Lengend Snippet: FOXO4-DRI promotes apoptosis in senescent cells. (A) Western blot analysis quantified changes in protein levels of BAX, Bcl2, and c-Caspase3 in different groups, with n = 5 per group. (B) Western blot analysis assessed changes in protein levels of BAX, Bcl2, and c-Caspase3 in the aortas of naturally aged mice after FOXO4-DRI or PBS treatment, with n = 5 per group. (C) Representative TUNEL staining and quantitative analysis were conducted to determine the number of positive cells in the aortas of naturally aged mice after FOXO4-DRI and PBS treatments, with n = 5 per group and scale bar = 100 μm. (D) Representative TUNEL staining and quantification evaluated the number of TUNEL-positive cells across different groups with n = 5 per group and scale bar = 20 μm. (E) Flow cytometry analysis was used to quantitatively assess the number of Annexin V-positive cells in different groups, with a sample size of n = 5 per group. Data are presented as mean ± SEM and analyzed using a two-tailed Student’s t-test. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: In the natural aging + FOXO4-DRI group, mice received intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days during the same period, followed by tissue collection.

Techniques: Western Blot, TUNEL Assay, Staining, Flow Cytometry, Two Tailed Test

Schematic illustration of FOXO4-DRI in alleviating endothelial cell senescence aging extends cell survival. This study demonstrates that FOXO4-DRI mitigates senescence by inhibiting the FOXO4-P53 interaction, promoting P53 phosphorylation, and inducing apoptosis in senescent cells, thereby alleviating aging-related symptoms. Content produced with BioRender; license VN28TABHO4.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway

doi: 10.3389/fbioe.2025.1729166

Figure Lengend Snippet: Schematic illustration of FOXO4-DRI in alleviating endothelial cell senescence aging extends cell survival. This study demonstrates that FOXO4-DRI mitigates senescence by inhibiting the FOXO4-P53 interaction, promoting P53 phosphorylation, and inducing apoptosis in senescent cells, thereby alleviating aging-related symptoms. Content produced with BioRender; license VN28TABHO4.

Article Snippet: In the natural aging + FOXO4-DRI group, mice received intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days during the same period, followed by tissue collection.

Techniques: Phospho-proteomics, Produced

Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad BioPlex 2200 p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Article Title: Characterization of HIV Humoral Immunity during Analytical Treatment Interruption

doi: 10.1016/j.jcv.2026.105930

Figure Lengend Snippet: Longitudinal serology in 3 representative participants (acute and chronic treated, post-treatment controller), including 5 different assays. ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad BioPlex 2200 p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).

Article Snippet: ATI duration is shown with gray shading, followed by ART re-initiation. (HIVc= Ortho Vitros HIV Combo; aHIV= Ortho Vitros HIV 1+2; LAg= Sedia Limiting Antigen avidity assay; Ag= BioRad BioPlex 2200 p24 antigen; M Ab= BioRad BioPlex 2200 HIV group M Ab).

Techniques: